These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1793331)

  • 1. [Perindopril and chronic heart failure].
    Bounhoure JP
    Arch Mal Coeur Vaiss; 1991 Dec; 84 Spec No 4():89-92. PubMed ID: 1793331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of perindopril in the treatment of chronic congestive heart failure. Multicenter double-blind placebo-controlled study.
    Bounhoure JP; Bottineau G; Lechat P; Garnham J; Lapeyre G
    Clin Exp Hypertens A; 1989; 11 Suppl 2():575-86. PubMed ID: 2691130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Contribution of perindopril to the treatment of chronic congestive cardiac insufficiency. Multicenter pilot double blind study versus placebo].
    Bounhoure JP; Bottineau G; Lechat P; Garnham J; Lapeyre G
    Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():73-8. PubMed ID: 2505716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative haemodynamic responses to the first dose of short- and long-acting ACE inhibitors in patients with congestive heart failure.
    Anthopoulos L; Apostolou T; Bonoris P; Foussas S; Lefkos N; Zombolos S
    Curr Med Res Opin; 2001; 17(4):290-7. PubMed ID: 11922403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of perindopril in pacing-induced canine models of acute and chronic heart failure.
    Ogilvie RI; Zborowska-Sluis D
    Can J Cardiol; 1995 Nov; 11(10):934-40. PubMed ID: 7489534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-dose response to angiotensin-converting enzyme inhibition in congestive cardiac failure: a Malaysian experience.
    Navookarasu NT; Rahman AR; Abdullah I
    Int J Clin Pract; 1999; 53(1):25-30. PubMed ID: 10344062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The long-term administration of perindopril improves the hemodynamic status of rats with heart failure].
    Medvedev OS; Zakharova NV
    Eksp Klin Farmakol; 1994; 57(6):26-9. PubMed ID: 7756952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.
    van Wijngaarden J; Smit AJ; de Graeff PA; van Gilst WH; van der Broek SA; van Veldhuisen DJ; Lie KI; Wesseling H
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):240-5. PubMed ID: 7511753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study.
    Ferrari R;
    Arch Intern Med; 2006 Mar; 166(6):659-66. PubMed ID: 16567606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
    Sigurdsson A
    Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of angiotensin converting enzyme inhibitors in the elderly: the example of perindopril.
    Forette F; McClaran J; Delesalle MC; Hervy MP; Bouchacourt P; Henry-Amar M; Santoni JP
    Clin Exp Hypertens A; 1989; 11 Suppl 2():587-603. PubMed ID: 2691131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study.
    MacFadyen RJ; Lees KR; Reid JL
    Br Heart J; 1991 Sep; 66(3):206-11. PubMed ID: 1657084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PROGRESS--perindopril protection against recurrent stroke study: status in July 1996. PROGRESS Management Committee.
    J Hypertens Suppl; 1996 Dec; 14(6):S47-51. PubMed ID: 9023716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal function, glycemic control and perindopril in diabetic patients.
    Brichard S; Ketelslegers JM; Lambert AE
    Clin Exp Hypertens A; 1989; 11 Suppl 2():545-54. PubMed ID: 2691128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term decrease of microalbuminuria after one year of treatment with perindopril in hypertensive diabetic patients].
    Brichard SM; Santoni JP; Thomas JR; Van de Voorde K; Ketelslegers JM; Lambert AE
    Ann Cardiol Angeiol (Paris); 1990 Oct; 39(8):495-9. PubMed ID: 2281920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double blind comparison of perindopril and atenolol in essential hypertension.
    Thurston H; Mimran A; Zanchetti A; Creytens G; Rorive G; Brown CL; Santoni JP
    J Hum Hypertens; 1990 Oct; 4(5):547-52. PubMed ID: 2283644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of perindopril on ambulatory intra-arterial blood pressure, cardiovascular reflexes and forearm blood flow in essential hypertension.
    West JN; Smith SA; Stallard TJ; Littler WA
    J Hypertens; 1989 Feb; 7(2):97-104. PubMed ID: 2647846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinctive properties of perindopril among converting enzyme inhibitors in congestive heart failure.
    Sami MH
    Can J Cardiol; 1994 Nov; 10 Suppl D():13D-16D. PubMed ID: 7954033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Captopril versus perindopril: a double blind study in essential hypertension.
    Lees KR; Reid JL; Scott MG; Hosie J; Herpin D; Santoni JP
    J Hum Hypertens; 1989 Feb; 3(1):17-22. PubMed ID: 2657055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The angiotensin-converting enzyme inhibitor perindopril in the treatment of congestive heart failure].
    Tereshchenko SN; Drozdov VN; Demidova IV; Levchuk NN; Moiseev VS
    Ter Arkh; 1997; 69(7):53-6. PubMed ID: 9424761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.